0001763894-19-000001.txt : 20190108
0001763894-19-000001.hdr.sgml : 20190108
20190108133449
ACCESSION NUMBER: 0001763894-19-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190108
DATE AS OF CHANGE: 20190108
EFFECTIVENESS DATE: 20190108
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tiburio Therapeutics Inc.
CENTRAL INDEX KEY: 0001763894
IRS NUMBER: 832309775
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-329946
FILM NUMBER: 19515483
BUSINESS ADDRESS:
STREET 1: 700 TECHNOLOGY SQUARE
STREET 2: 3RD FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-231-6020
MAIL ADDRESS:
STREET 1: 700 TECHNOLOGY SQUARE
STREET 2: 3RD FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
D
1
primary_doc.xml
X0708
D
LIVE
0001763894
Tiburio Therapeutics Inc.
700 TECHNOLOGY SQUARE
3RD FLOOR
CAMBRIDGE
MA
MASSACHUSETTS
02139
617-231-6020
DELAWARE
None
None
Corporation
true
2018
Christoph
M.
Adams
700 Technology Square
3rd Floor
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
Director
Mette
Kirstine
Agger
700 Technology Square
3rd Floor
Cambridge
MA
MASSACHUSETTS
02139
Director
Sandip
Agarwala
700 Technology Square
3rd Floor
Cambridge
MA
MASSACHUSETTS
02139
Director
David
Mott
700 Technology Square
3rd Floor
Cambridge
MA
MASSACHUSETTS
02139
Director
Sara
Nayeem
700 Technology Square
3rd Floor
Cambridge
MA
MASSACHUSETTS
02139
Director
Abraham
N.
Ceesay
700 Technology Square
3rd Floor
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
James
G.
McArthur
700 Technology Square
3rd Floor
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2018-12-20
false
true
false
0
31000001
5000001
26000000
false
5
0
0
0
false
Tiburio Therapeutics Inc.
/s/ Abraham N. Ceesay
Abraham N. Ceesay
CEO and President
2019-01-08